NCT01947634
- Conditions
- Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +19 more
- Locations
-
- University Hospital Zurich, Division of Internal Medicine Zurich, Canton of Zurich, Switzerland
Clinical trial condition
Fabry Disease
Explore clinical trials studying Fabry Disease. Study availability and eligibility vary by location and protocol.
175 public trials
38 recruiting studies
Fabry Disease trial results
NCT01997489
- Conditions
- Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +19 more
- Locations
-
- Ulla Feldt-Rasmussen Copenhagen, Capital Region, Denmark
- National University Hospital, Department of Medical Endocrinology Copenhagen, Denmark
NCT01650779
- Conditions
- Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +19 more
- Locations
-
- Coral Springs, Florida, United States
- Decatur, Georgia, United States
- Baltimore, Maryland, United States
- Grand Rapids, Michigan, United States
NCT02082327
- Conditions
- Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +19 more
- Locations
-
- PRA International Groningen, Netherlands
NCT01632111
- Conditions
- Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +19 more
- Locations
-
- University Hospital Zurich, Division of Internal Medicine Zurich, Switzerland
Completed
Paricalcitol in Fabry Disease
NCT02090608
- Conditions
- Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +29 more
- Locations
-
- federico II university, department of nephrology Naples, Italy
NCT00074984
- Conditions
- Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +19 more
- Locations
-
- University of Alabama at Birmingham Birmingham, Alabama, United States
- Cedars-Sinai Medical Center Los Angeles, California, United States
- University of San Francisco San Francisco, California, United States
- University of Connecticut Health Partners Farmington, Connecticut, United States
Completed
A Study to Assess the Absorption, Metabolism and Excretion of Migalastat Hydrochloride (AT1001-014)
NCT01730482
- Conditions
- Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +19 more
- Locations
-
Not specified
Completed
Migalastat Food Effect Study
NCT01489995
- Conditions
- Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +19 more
- Locations
-
- GSK Investigational Site Austin, Texas, United States
- Conditions
- Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +19 more
- Locations
-
- GSK Investigational Site Randwick, New South Wales, Australia
Related conditions
- Brain Diseases (175)
- Brain Diseases, Metabolic, Inborn (175)
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities (175)
- Genetic Diseases, X-Linked (175)
- Lipid Metabolism, Inborn Errors (175)
- Lysosomal Storage Diseases, Nervous System (175)
- Metabolism, Inborn Errors (175)
- Nutritional and Metabolic Diseases (175)